Skip to main content
Clinical Trials/NCT01072474
NCT01072474CompletedPhase 3

Capnography as an Adjunct to Standard Monitoring During Midazolam and Propofol Sedation for ERCP

Technical University of Munich6 sites in 1 country242 target enrollmentStarted: February 1, 2010Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
242
Locations
6
Primary Endpoint
Hypoxemia

Study Overview

Brief Summary

In the study the value of capnography for avoiding complications during sedation for ERCP is evaluated.

Detailed Description

In this randomized controlled trial the utility of capnography gets evaluated. Hypoxemia may occur during sedation with midazolam and propofol. Whether hypoxemia may be prevented by an additional capnographic monitoring is subject of the study.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Scheduled for colonoscopy with midazolam and propofol sedation

Exclusion Criteria

  • No informed consent
  • Pregnancy
  • Prexisting hypotension, bradycardia or hypoxemia

Outcomes

Primary Outcomes

Hypoxemia

Time Frame: From the beginning to the end of the ERCP procedure, i.e. from 0h to approximately 2h

Secondary Outcomes

  • Further complications(From the beginning to the end of the ERCP procedure, i.e. from 0h to approximately 2h)

Investigators

Sponsor
Technical University of Munich
Sponsor Class
Other

Study Sites (6)

Loading locations...

Similar Trials

Capnography During ERCP | Clinical Trial